ACCME Accreditation

The Clinical Immunology Society (CIS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education to physicians. CIS current accreditation is valid until March 31, 2022.


CIS directly sponsors CME for its own programs and jointly providership CME for other related organization programs. The CME program is overseen by the CIS Executive Committee and CME Committee.


The CIS CME program operates in a health care environment where the patients that meeting participants treat, range across a broad spectrum of clinical immunology. Patients of the physician participants in the CME Program can be found in specific areas such as Allergy/Asthma, HIV, Primary Immune Deficiencies, Immunology of Diabetes/Endocrine Disorders, Autoimmune Disorders, Rheumatoid Arthritis, Multiple Sclerosis (and other Neuroimmunologic Disorders), Systemic Lupus Erythematosus, Mucosal Immunology related diseases, Transplantation (Organ/Bone Marrow), Inflammatory Eye Diseases, Rheumatology, Immunohematology and Tumor Immunology.


The leadership of CIS views CME as a strategic initiative and an important member benefit in this time of changing medical education. The CIS CME program uses practice-based needs to match the content of programs to the learner’s scope of practice, in addition to his or her future or potential scope of practice, to measure change in competence.


CME Mission Statement

  • The purpose of the CME program is to link new information from the basic science laboratory and clinical research with clinical applications in the patient care setting, in order to improve patient care.
  • The content areas of the CME program deal with advances in the prevention, diagnosis and treatment of diseases in the immune system.
  • The target audience includes, but is not limited to the members of CIS and includes interested physicians, scientists, trainees, and other health care professionals who are involved with clinical immunology (both national and international).
  • The types of activities are annual scientific meetings, satellite meetings, and smaller conferences such as single-topic symposia and post-graduate courses.
  • The expected results are to enhance the competence of health care providers who use immunodiagnostics, treat patients with immunologic disorders and prescribe immunotherapy. We will encourage the dissemination and investigation of scientific and clinical information relevant to the field; promote the interchange of opinions regarding the application of clinical immunology to patient care and management; and, provide a forum for workers in the field to meet, and to develop excellence in research and immune related clinical applications.